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AbstrACt
Objectives The aim of this study was to understand 
causes of attendance and non-attendance to a follow-up 
cervical cancer screening among human papillomavirus 
(HPV)-positive women.
Design Semistructured, individual interviews with HPV-
positive women and cervical cancer screening nurses. 
The interview guide and initial data analysis were guided 
by existing health behaviour theories. However, as the 
theories limited the potential of the data material, a 
grounded theory framework guided the final data analysis.
setting Interviews were conducted in Dar es Salaam, 
Tanzania, at Ocean Road Cancer Institute (ORCI) or in the 
homes of screening clients.
Participants 15 interviews were conducted with women 
who had tested HPV-positive during a patient-initiated 
screening and been appointed for a follow-up screening 
14 months later. Nine women had not attended the follow-
up appointment, four had delayed attendance and two 
had attended on the scheduled date. Further, individual 
interviews were conducted with the two nurses working at 
ORCI’s screening clinic.
results Perceived benefits for attending a patient-
initiated screening include treatment of gynaecological 
symptoms and prevention of disease. The key perceived 
benefit of a health provider-initiated follow-up screening is 
prevention, which is challenged by the circumstance that 
it is seen by women as having merely potential benefit and 
therefore can be postponed when competing needs are 
present. Perceived challenges for screening attendance 
include emotional costs, in the form of fear of the disease, 
fear of the gynaecological examination as well as direct 
and indirect economic costs, such as transportation costs, 
lost income and waiting time.
Conclusion Cervical cancer screening is one among 
many tasks that women living in a low-income setting 
must attend to. Since health provider-initiated follow-
up screening is seen as having only potential benefit, 
attendance can be postponed when competing needs 
exist.
trial registration number NCT02509702.
IntrODuCtIOn   
When walking into the cervical cancer screening 
clinic at Ocean Road Cancer Institute (ORCI) in 
Dar es Salaam, Tanzania, it is evident that 
cervical cancer is a tremendous health issue. The 
line of women in the shaded waiting area is long 
and starts early every morning Monday–Thursday 
in order for women to receive one of the 25 unsched-
uled screening appointments. Twenty-five is the 
number of clients the two screening nurses can 
attend to each day apart from the screenings with 
clients that have been scheduled for a follow-up 
appointment. If a woman arrives late and misses 
one of the appointment numbers, she has to return 
another day (field note, first author).
East Africa is the region of the world that has 
the highest incidence rate (42.7 per 100.00 
women) and mortality rate (27.6 per 100.000 
women) of cervical cancer.1 The disease is a 
major public health issue in Tanzania, and 
with an incidence and mortality rate of 54.0 
and 32.4 per 100.000 women, respectively, 
the burden of disease exceeds the regional 
average.2 The high prevalence of human 
papillomavirus (HPV) (20%)3 4 and limited 
screening options are contributing factors to 
the cervical cancer burden in Tanzania.3 5 6 
strengths and limitations of this study
 ► This is the first qualitative study in Africa that elu-
cidates what motivates and prevents HPV-positive 
women from returning to a health-provider initiated 
follow-up cervical cancer screening.
 ► Based on our findings, we have developed a the-
oretical model for perceived costs and benefits 
of screening attendance, which potentially can 
be generalised to other screening scenarios and 
help understand screening behaviour in a broader 
perspective.
 ► Recruitment for this study was difficult and eligible 
participants included both women who had attended 
and not attended a follow-up screening. A more nu-
anced view may have appeared if participants had 
been limited to only one of these groups.
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Cervical cancer screening is free of charge in Tanzania, 
and the standard is patient-initiated screening, which 
involves a gynaecological examination with visual inspec-
tion of the cervix after application of acetic acid (VIA) 
or lugol’s iodine. However, rapid HPV DNA testing 
either through provider-based or self-sample tests3 6–8 is 
currently being tested as alternative screening methods.9 
If a woman tests HPV-positive, she will be asked to return 
for a health provider-initiated follow-up screening. If diag-
nosed with cervical cancer, she will be treated according 
to the National Cervical Cancer Service Delivery Guide-
lines. This involves a biopsy and referral for treatment at 
the oncology clinic at ORCI, which is free of charge.
Effective screening programmes are key elements 
to overcoming the burden of disease in Africa, and a 
number of studies have investigated screening uptake 
barriers and determinants in Africa. Generally, studies 
show that the uptake of screening programmes is limited 
(10%–29%)6 10–13 and associated with a complex set of 
individual, social and structural factors, for example, 
husband’s approval,11 14 15 distance to clinic,11 13 16 gender 
of health professional,10 financial constraints, prioritising 
more contending needs when feeling healthy17 and fear 
of results, discrimination, pain or embarassment.7 11 13–17 
The literature on follow-up after screening is limited. 
Two studies from South Africa address non-attendance 
for a scheduled follow-up visit18 and experiences with the 
referral pathway19 after having an abnormal pap smear, 
and one study from Nigeria, concern non-attendance for 
a scheduled follow-up visit after testing VIA-positive.20 
The studies found that only 47%18 and 53%18 returned 
for their follow-up appointments, and that the main 
reasons for non-attendance were time constraints and 
transportation costs.20 Further, women reported that 
having a gynaecological symptom was the most common 
reason for having a Pap smear while negative community 
opinions, fear of having an HIV test and low encourage-
ment from peers were potential access barriers.19 To our 
knowledge, no studies have explored African women’s 
experience with testing HPV-positive and reasons why 
health provider-initiated follow-up screenings may be 
defaulted among this group of women. It is important to 
understand the views of these women in order to make 
future screening programmes that involve HPV-testing 
more effective.
study context and objectives
This paper is based on a qualitative study embedded in a 
randomised trial called Connected2Care (NCT02509702). 
The trial aims to assess the effect of short message 
service (SMS) on attendance at a health-provider initi-
ated cervical cancer follow-up screening among women, 
who have tested HPV-positive during a patient-initiated 
screening. Both the patient-initiated and health provid-
er-initiated screening entailed a gynaecological examina-
tion. The trial started in 2015 and is to finish in 2018. The 
study protocol is published elsewhere.9
The qualitative study had two aims: (1) to understand 
reasons for (non)attendance to a health provider-initi-
ated follow-up screening among HPV-positive women and 
(2) how these women perceive the SMS intervention. This 
paper focuses on the first objective and elucidates what 
motivates or prevents HPV-positive women from returning 
for a follow-up screening. The results of the second qual-
itative objective will be reported elsewhere.
MethODs
study site and sampling
This study was conducted in July 2017 in Dar es Salaam, 
Tanzania (figure 1). Participants were purposively sampled 
and consisted of cervical cancer screening nurses working 
at ORCI and of women who live in the Region of Dar es 
Salaam, who had tested HPV-positive during a patient-initi-
ated screening. Screening clients were eligible for interviews 
if they were HPV-positive, been scheduled for a 14 months 
follow-up appointment, were randomised to receive SMSs, 
and had either attended or missed the follow-up appoint-
ment. Eligible women were approached over phone in a 
consecutive order starting with those who had not attended 
their follow-up appointment to those that had delayed atten-
dance and those who attended at the scheduled appoint-
ment date. All nurses working at the screening clinic were 
eligible for interviews and approached in person.
Data collection
A total 31 HPV-positive women were approached for inter-
views, and 15 individual semistructured interviews were 
conducted; nine women had not attended this appoint-
ment, four had delayed attendance and two had attended 
Figure 1 Map of Tanzania32 showing location of Dar es 
Salaam.
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on the scheduled appointment date. The first author, who 
is female and had experience with qualitative data collec-
tion and analysis, interviewed all participants. Data collec-
tion stopped once data were saturated. All interviews were 
done in Kiswahili with simultaneous English translation. The 
translator was a female social worker from ORCI who was 
briefed about the study objectives prior to interviews. A total 
of three nurses were eligible for interviews; however, one was 
on maternity leave during the data collection period. There-
fore, two individual interviews were conducted in English 
with screening nurses. All participants were given a bar of 
soap as a gift of gratitude.
Interviews were conducted in the women’s homes or 
in a private room at ORCI with the location being based 
on the preference of the participant. When interviews 
were conducted at ORCI, transport costs were refunded. 
The interviews took place between 09:00 and 17:00 hours 
and lasted 21–54 min with an average of 36 min. No other 
persons were present except the primary investigator, the 
translator and the participant. All interviews were audio-
taped and later transcribed verbatim by a professional 
Tanzanian transcriber specialised in language studies, 
who also served as validator of the translation. Transcripts 
showed that minor translation errors occurred 15 times 
and the correct translation was written in the transcript. 
Written field notes supplemented the data, and each 
interview was debriefed once finished.
The final interview guide consisted of 30 questions 
(online supplementary file 1) and was inspired by other 
qualitative studies within the field of mobile health.21 22 It 
was pretested in the winter, 2015 and spring, 2016 during 
a pilot study conducted in Bagamoyo, Pwani Region, 
which is 50 km from Region of Dar es Salaam. The guide 
was slightly modified during the first interviews in July 
2017. Sociodemographic characteristics for each client 
were derived from a questionnaire that had been filled 
out during their initial screening.
theoretical framework
The data collection tool was guided by the Healthcare Access 
Barrier (HCAB) model,23 the theory of planned behaviour24 
and the technology acceptance model.25 The HCAB model 
also guided the initial coding and data analysis; however, as 
analysis progressed, it was apparent that the model limited 
the potential of the material. Therefore, Grounded Theory 
guided the further analysis where codes and theory were 
constructed based on the material.26 This enabled the anal-
ysis to stay close to the women’s own experiences of the 
factors that motivated or prevented them from attending 
screening.
Data analysis
NVivo 11 ( www. qsrinternational. com) was used for data anal-
ysis. A content analysis was conducted and data was coded 
into central themes by the use of a coding frame.27 28 The 
coding frame was developed in a two-step process. First, all 
data were coded in a combined inductive-deductive manner 
where central themes were deducted from the above-men-
tioned health theories and supplemented by inductive cate-
gories that arose from the transcripts. One researcher read 
through and coded all transcripts in this step. To test the reli-
ability of the coding, a second peer researcher who was not 
familiar with the research field coded approximately 20% 
of the transcripts. The double coding process showed that 
the coding frame was promising; however, it led to a revision 
of some codes and subsequently to a consideration whether 
the coding frame was limited by the guiding theories. Conse-
quently, data were recoded with a modified coding frame 
that only contained inductive categories that arose from the 
data (table 1).
At the end of the coding process, each transcript ID was 
replaced by a pseudonym and the top 17 names for Tanza-
nian women were used.29 To avoid the translation link, 
‘she’ was replaced with ‘I’ in the transcripts. The study 
was reported according to the Standards for reporting 
qualitative research guidelines.30
Patient and public involvement
Clients were not involved in the design or recruitment of 
the study. However, study participants were contacted and 
offered to comment on the final data analysis.
ethical considerations
Ethical clearance for the overall Comprehensive Cervical 
Cancer Prevention in Tanzania (CONCEPT) study (online 
supplementary file 2), of which Connected2Care is a substudy, 
Table 1 Elements of final coding frame
Primary category First subcategory
Secondary 
subcategory
Third
subcategory Fourth subcategory
Perceived costs Economic Direct Work –
Transport – 
Indirect Time Accessibility
Family obligations
Emotional Examination – – 
Disease – – 
Perceived benefits Symptoms – – – 
Prevention – – – 
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was obtained from the National Institute for Medical 
Research in Tanzania, reference number NIMR/HQ/R.8a/
Vol. IX/1955. Informed consent was read to all participants 
(online supplementary file 3) and everyone consented and 
signed the consent form prior to data collection starting.
FInDIngs
Characteristics of participants
The mean age for the screening clients was 38.6 years and 
the majority had finished primary education (67%) and 
were monogamously married (67%). Sixty per cent were 
Muslim, 33% were Christian and 1 did not disclose her 
religion. Further, 67% were HIV-negative, and 33% were 
HIV-positive. Eighty per cent had not been screened prior 
to the screening where they tested HPV-positive (table 2).
the context of screening clients
The data collection mirrors the complex context that 
defines the daily lives of Tanzanian women. This context 
needs to be taken into account when wanting to under-
stand reasoning for screening behaviour.
Fifteen out of 31 (48%) approached women accepted 
to participate in the interviews. Reasons for non-partici-
pation were: travelling outside Dar es Salaam (n=5), work 
obligations (n=3), husband had recently died (n=2), 
woman had died (n=2), woman did not wish to participate 
(n=2), woman had developed cancer (n=1), and woman 
was on maternity leave (n=1). Moreover, six women did 
not pick up when calling to invite them into the study.
Perceived benefits of screening
During the interviews, the benefits of attending screening 
were discussed. Two women could not explain why they 
had attended screening, five said it was because of health 
preventive reasons. Eight stated it was due to symptoms 
they wanted to be examined for.
Treatment of symptoms
Women mainly described their reasons for going for 
the patient-initiated screening as the majority had not 
returned for the health provider-initiated follow-up 
screening. Most stated that they went in the first place 
due to gynaecological symptoms, which worried them. 
However, these were not necessarily related to onco-
genic HPV. Grace said that she had a ‘[…] certain kind 
of discharge from the vagina’ (Grace) while Mary described 
that, ‘I was itchy in my private parts’ (Mary). Editha had the 
following reasoning,
My legs used to be numb, and I went to several hos-
pitals and bought drugs from pharmacies for al-
most a year without noticing any improvements. At 
one point, I went to a hospital […] and the doctor 
(asked) […] if I bleed during sexual intercourse to 
which I answered yes […]. At that point, the doc-
tor advised me that I should go for cervical cancer 
screening. (Editha)
The nurses agreed that many women come for screening 
when they have an urging health concern,
Most of the clients […] have problems forcing them 
to come. One of the problems is infertility. They 
say they want to go through cancer screening but 
they don’t have children. That is why they come for 
screening […]. Others come here because they have 
Table 2 Characteristics of screening clients
Characteristics N (%)
Age
  Mean 38.6
  Min. 27
  Max 55
Educational level
  Primary (standard 5–7) 10 (66%)
  Lower secondary (form 1–4) 3 (20%)
  Upper secondary (form 5–7) 1 (7%)
  University/College 1 (7%)
Marital status
  Married monogamous 10 (66%)
  Married polygamous 2 (13%)
  Divorced/Widow 2 (13%)
  Single 1 (7%)
Living conditions
  Husband/cohabiter 12 (80%)
  Other relatives 2 (13%)
  Nobody 1 (7%)
Religion
  Muslim 9 (60%)
  Christian 5 (33%)
  Missing 1 (7%)
HIV
  Negative 10 (67%)
  Positive 5 (33%)
HPV
  Positive 15 (100%)
  Negative 0
Screened prior to HPV test screening
  No 12 (80%)
  Yes 3 (20%)
Attendance follow-up screening (14 months 
past rapid HPV test)
  Attended on scheduled appointment 
date
2 (13%)
  Attended between 7 and 120 days of 
scheduled appointment
4 (27%)
  Did not attend scheduled appointment 9 (60%)
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referral letters. […] Some complain about lower ab-
dominal pain. (Sister Victoria)
Preventive health behaviour
Awareness of cervical cancer and the possibility of 
preventing oneself from getting sick was another major 
reason for prioritising to go for screening,
I went for screening […] just for check-up. I did not 
have any symptoms. […] Awareness is increasing. I 
see more women going to the hospital even if they 
have no symptoms. (Irene)
Mona Lisa described her reflections this way,
I wanted to know my health. […] I thought it is bet-
ter to come early for screening despite the fact that I 
didn’t have any symptoms, so that I could get treated 
early in case I had a problem. (Mona Lisa)
When discussing the reasons for going, it was clear that 
the benefits of coming had to be balanced against the 
challenges, which screening also entailed.
Perceived costs of screening
All women outlined a number of costs, which they 
personally experienced or expected others to have, when 
deciding whether or not to go for screening. This cost-ben-
efit dilemma was present both when having to decide to 
go for the patient-initiated and health provider-initiated 
screening. However, often the challenges of returning for 
health provider-initiated follow-up screening outweighed 
the benefits of going, partly due to the screening only 
entailing the potential benefit of prevention. And partly 
due to a repeated gynaecological examination and the 
challenging label of being HPV-positive.
Emotional costs due to fear of the examination
The gynaecological examination was an element that 
several women described as a factor that prevented them 
from returning to screening. Grace said that,
I think they [ed. women] do not come back because 
of the nature of the screening itself—the gynaeco-
logical examination. It scares them off and it can be 
painful at times. I am one of the people who are also 
afraid. I really wanted to go back but when I thought 
about the gynaecological examination, I said ‘now 
I’m not going back’. (Grace)
A few women thought the examination entailed that 
the cervix was pulled outside the body during the exami-
nation, which frightened them,
The process [ed. examination] was improper as it in-
volved pulling out, squeezing, the cervix. Pulling out 
or squeezing the cervix really hurts. There is pain. 
(Jacklen)
In contrast, several women described the examina-
tion as ‘just fine’ (Happy/Editha), and most stated that 
they felt the nurses treated them really good despite the 
examination being somewhat uncomfortable. The nurses 
supported the women’s statements that fear of the exam-
ination kept some away. But they also experienced that 
most women talked to them about their concerns,
[…] some of them have the fear, but many appreciate 
the examination—‘oh, I thought it was going to be 
painful, but it was not painful’. (Sister Lucky)
Emotional costs due to fear of disease
Cervical cancer was perceived as a dangerous disease that 
was linked to ‘death’ and several women described that it 
was ‘worse than HIV’ (Grace/Irene/Editha). Glory said that,
In case the results are bad, it is like the end of life. 
There is nothing to do. If you have cancer, then you 
are going to die. (Glory)
Despite numerous women stating that they went for an 
initial screening for preventive reasons it appeared that—
contrary to what was expected—the preventive nature 
often vanished once the women found themselves in the 
grey zone of being HPV-positive—having an increased 
risk but still not a patient with cancer. The label of being 
HPV-positive seemed difficult to comprehend and some 
feared they would be diagnosed with cancer if they 
returned,
They [ed. women] are afraid that if they come for 
check-up they will be found to have the disease. […] 
It is said that cancer is more worse than HIV/AIDS. 
So that means when you have cancer you are dead. 
(Editha)
Others interpreted the label ‘HPV-positive’ as being 
‘fine’ and ‘not sick enough’, hence they prioritised more 
urgent needs in their daily lives,
Initially, I was very worried. When the nurses told me, 
they were coming to see me I thought that I already 
have cancer. […] They […] told me that I am HPV-
positive, but it doesn’t mean I have cancer. […] So, 
I was supposed to come back for check-up […] but I 
didn’t come. […] I know that I still have the infection 
and I would like to come, but […] family and eco-
nomic problems, including not being able to afford 
transport to the clinic, made me not attend the clinic. 
(Gladness)
Both fear and other competing challenges were 
elements the nurses also outlined,
They don’t like to come because of the fear of HPV, 
because they think when they are found to be HPV-
positive that will be the end of their life. ‘I don’t want 
to hear again about HPV. I want to forget about it.’ 
That is what they think. […] Others they cannot 
come because they live far from their site of screen-
ing. But also, some of them they don’t have money 
for transport to come for screening. (Sister Lucky)
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Further, it appeared that whereas some women had a 
good understanding of HPV, others had not understood 
that they had tested HPV-positive and what that meant. 
While Mona Lisa said that ‘I have HPV virus that causes 
cervical cancer’ (Mona Lisa), Irene stated that, ‘I don’t know 
if I [am] HPV-positive’ (Irene). Jacklen had expected to 
receive medicine when testing HPV-positive,
I have been told by a nurse […] I [am] found to have 
HPV infection […]. What kind of medication am I 
going to receive? Because I didn’t [ed. receive any 
medication]. (Jacklen)
Direct economic costs
Despite the screening being cost free, related economic 
costs delayed or kept women from returning. Irene 
outlined her tough priorities this way,
Sometimes I don’t have the money for transport. It is 
like, ‘ah, I only have 2000 shillings [ed. less than USD 
1]—should I use it to go to the hospital or buy food 
for the children?’. (Irene)
On top of the costs of transport, the screening also 
meant that income was lost the day they went (box 1). 
Jacklen put it this way,
If I go for examination now I will not be able to go sell 
my fish. (Jacklen)
Indirect economic costs
Apart from the direct economic cost, other indirect costs 
such as time spent accessing the clinic and the waiting 
time at the clinic were contributing factors to why 
returning for a screening was not a top priority. Catherine 
described it this way,
There is a certain number of patients served per day. 
It is twenty per day. So, if you are late you will not 
get any service, they will ask you to return the follow-
ing day. I have responsibilities (and) I want to go for 
screening. But I am afraid that if I arrive there late 
all the numbers will be already gone and [I] will be 
asked to come the next day. (Catherine)
Editha perceived the issue as such,
Others come from upcountry and they come here for 
screening the first time but they find it difficult to 
return. […] When you come back tomorrow you will 
find another huge crowd. (Editha)
DIsCussIOn
This study shows that health provider-initiated follow-up 
cervical cancer screening attendance among Tanzanian 
HPV-positive women is a complex phenomenon, which 
is challenged by competing concerns. Motivating factors 
for patient-initiated screening involve treatment of gynae-
cological symptoms and prevention of disease. However, 
the key element of a health provider-initiated follow-up 
screening is prevention, which can be seen as a ‘potential 
benefit’ as a long as the woman is healthy. Hence, this 
can be postponed when other more immediate concerns 
overshadow this need. Challenges that prevent or delay 
women from returning include emotional and economic 
costs, such as the difficult label of being HPV-positive, 
fear of the gynaecological examination, loss of time and 
transport costs.
The screening dilemma found in this study can be 
conceptualised as a theoretical screening attendance 
model (figure 2). The model shows how screening atten-
dance is an action, where women have to account for both 
the costs and benefits of going. While the same costs are 
present for both patient-initiated and health provider-ini-
tiated screening, the health provider-initiated follow-up 
screening is challenged by the circumstance that it only 
contains the potential benefit of prevention. The terms 
‘costs’ and ‘benefits’ are inspired by health economic 
cost-benefit theory.31 However, in this model they are used 
as general concepts and not as quantifiable measures. As 
this model is developed based on these study findings 
alone, future studies may test the validity of the model.
To our knowledge, this is the first study in Africa where 
HPV-positive women have been followed up and asked 
box 1 Catherine’s story
Today we visited Catherine who had not come for her check-up ap-
pointment. She was […] wearing a blue scarf and we could hear the 
chickens outside while sitting on the floor of her living room when she 
told us her story. (Field note, first author)
Catherine:
Before I went for the screening I had certain symptoms – like […] heavy 
[…] menstrual blood during periods. And also, I had irregular periods. 
[…] And when I had sexual intercourse I had pain […] [and] a lot of 
blood came out. That is why I decided to go for check-up at Ocean 
Road. When I went for the check-up I was found to have a tumour in 
my cervix. […] So, Ocean Road took a biopsy to make sure whether it 
was cancer or not. After 1 week, they called me to go for my results. 
[…] On that day when I went for the results I was very worried. And 
during the week of waiting for the results I was very worried and totally 
sick. So, when they told me that my results are good (ed. the tumour 
was not cancer) (…) I was very happy. The happiest lady in the world. 
After 2 days I had a surgery and the surgery was successful [ed. the 
tumour was removed]. […] I went back to Ocean Road twice [ed. for 
post surgery check-up]. Sister Victoria is the one who screened me. She 
told me ‘now you are fine, you can bear a child. [Ed. at this last post-sur-
gery screening she tested positive for HPV and was given a follow-up 
appointment 14 months later].
I was supposed to come back in April. […] I saw it, but I had no time. 
[…] There is something surrounding me making me not to come back. 
But I want to come back! [It] is because of the hard-economic situation. 
Women are now running searching for food. People are running selling 
vegetable, selling… so that they can get something to eat. But when 
they find themselves sick, they will go back to for check-up. I’m just 
feeling good, I will go next week […]. You see, we Tanzanians, when we 
are healthy we won’t come back…
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for their reasons for attending a health provider-ini-
tiated follow-up appointment or not. Therefore, the 
comparability of the study results is somewhat limited. 
When comparing our results to a study for Nigeria that 
concerns default of follow-up for VIA, the results are 
moderately comparable. Similar to our study, the Nige-
rian study finds financial and time constrains as reasons 
for defaulting a follow-up appointment; however, it does 
not document emotional costs.20 When comparing our 
findings to studies that focus on facilitators and barriers 
of screening uptake, we see that in line with our study, a 
South African study documents the presence of gynaeco-
logical symptoms as an important reason for patient-ini-
tiated screening. However, it also documents the fear of 
having a HIV-test at the same time as the Pap smear and 
low support from peers as potential access barriers, which 
we did not find in this study.19 Similar to our study, other 
studies also report both emotional and economic barriers 
for screening uptake11 13–17 as well as women prioritising 
more contending needs when feeling healthy.17 Yet, 
they also report factors that influence uptake, which 
was not documented by this study, such as husband’s 
approval.11 14 15 It is plausible that facilitators and barriers 
for patient-initiated screening and health provider-initi-
ated follow-up screening somewhat overlap. However, 
further research is needed to confirm this.
Limitations
This study reflects perceptions among screening nurses 
and HPV-positive women in Dar es Salaam and may show 
only one fraction of the complex picture of what affects 
screening follow-up behaviour among HPV-positive 
women. Eligible participants included screening nurses 
and women who had not attended, had delayed atten-
dance or timely attended a follow-up screening. Despite 
the fact that data collection stopping when saturation was 
reached, it is plausible that a more nuanced view would 
have appeared if eligible participants had been limited 
to one of these groups. However, recruitment was diffi-
cult, and we experienced that both attending and non-at-
tending clients shared many considerations.
Lessons learnt
This qualitative study is part of larger complex interven-
tion study called Connected2Care that aims to increase the 
number of HPV-positive women that returns for follow-up 
cervical cancer screening and understand the underlying 
causes of cervical cancer screening behaviour. Together 
with the overall Connected2Care project, this qualitative 
study may help guide future complex interventions and 
screening programmes that involves HPV-testing in an 
African setting. Key elements that are identified in this 
substudy include perceived obstacles for returning for 
screening, such as fear of gynaecological examination, 
loss of time and transportation costs. If these findings are 
confirmed by other large-scale studies, future screening 
programmes could try to address these obstacles, for 
example, by conducting the follow-up screening as part 
of an outreach service with self-sample HPV test.
COnCLusIOn
Tanzanian women’s lives are filled with tough priori-
ties, and in this context of competing obligations and 
concerns, attending to one’s own personal health may 
not always be the top priority. This qualitative paper has 
Figure 2 Screening attendance model.
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documented that the status as ‘HPV-positive’ is a difficult 
label, and that the key element of a health provider-ini-
tiated follow-up screening is ‘prevention’, which can be 
postponed when other more immediate concerns are 
present. The potential benefit of prevention does not 
necessarily outweigh the emotional and economic cost of 
attending a follow-up screening.
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